A phase i study of concurrent chemotherapy and thoracic radiotherapy with oral epigallocatechin-3-gallate protection in patients with locally advanced stage III non-small-cell lung cancer

Radiotherapy and Oncology

Volumn 110, Issue 1, 2014, Pages 132-136

  Zhao, Hanxi ^a   Zhu, Wanqi ^a   Xie, Peng ^a   Li, Huiqin ^a   Zhang, Xiqin ^a   Sun, Xiaorong ^a   Yu, Jinming ^a   Xing, Ligang ^a  

^a SHANDONG CANCER HOSPITAL AND INSTITUTE   (China)

Author keywords

EGCG; Non small cell lung cancer; Phase I study

Indexed keywords

CISPLATIN; EPIGALLOCATECHIN GALLATE; ETOPOSIDE; ANTINEOPLASTIC AGENT; CATECHIN;

ACUTE RADIATION INDUCED ESOPHAGITIS; ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER PAIN; CANCER RADIOTHERAPY; CARDIOVASCULAR DISEASE; CHEMORADIOTHERAPY; CHEMOTHERAPY INDUCED ANEMIA; CHEMOTHERAPY INDUCED NAUSEA AND VOMITING; CLINICAL ARTICLE; COHORT ANALYSIS; COMPUTER ASSISTED RADIOTHERAPY; DISEASE EXACERBATION; DOSE RESPONSE; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG SAFETY; DRUG TOXICITY; DYSPHAGIA; ESOPHAGITIS; FEASIBILITY STUDY; FEMALE; GASTROINTESTINAL SYMPTOM; GASTROINTESTINAL TOXICITY; HEARTBURN; HISTOPATHOLOGY; HUMAN; INFECTION; KIDNEY DISEASE; LUNG ADENOCARCINOMA; LUNG FIBROSIS; LUNG NON SMALL CELL CANCER; MALE; MIDDLE AGED; MULTIPLE CYCLE TREATMENT; NEUROLOGIC DISEASE; NEUTROPENIA; PAIN ASSESSMENT; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; QUALITY OF LIFE; RADIATION DOSE; RADIATION INJURY; RADIATION PROTECTION; RADIOTHERAPY PLANNING SYSTEM; RESPIRATORY TRACT DISEASE; SKIN DISEASE; THROMBOCYTOPENIA; TREATMENT RESPONSE; TUMOR DIFFERENTIATION; UNSPECIFIED SIDE EFFECT; ANALOGS AND DERIVATIVES; CANCER STAGING; CARCINOMA, NON-SMALL-CELL LUNG; CLINICAL TRIAL; LUNG NEOPLASMS; PATHOLOGY;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; CATECHIN; CHEMORADIOTHERAPY; CISPLATIN; ESOPHAGITIS; ETOPOSIDE; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; RADIOTHERAPY DOSAGE;

EID: 84896078460     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2013.10.014     Document Type: Article

References (31)

1. G. Mantini, V. Valentini, and B. Meduri et al. Low-dose radiotherapy as a chemo-potentiator of a chemotherapy regimen with pemetrexed for recurrent non-small-cell lung cancer: a prospective phase II study Radiother Oncol 105 2012 161 166
2. L. Wang, S. Wu, and G. Ou et al. Randomized phase II study of concurrent cisplatin/etoposide or paclitaxel/carboplatin and thoracic radiotherapy in patients with stage III non-small cell lung cancer Lung Cancer 77 2012 89 96
3. J.L. Lopez Guerra, Q. Wei, and X. Yuan et al. Functional promoter rs2868371 variant of HSPB1 associates with radiation-induced esophageal toxicity in patients with non-small-cell lung cancer treated with radio(chemo)therapy Radiother Oncol 101 2011 271 277
4. R. Mitrica, I. Dumitru, and L.L. Ruta et al the dual action of epigallocatechin gallate (EGCG), the main constituent of green tea, against the deleterious effects of visible light and singlet oxygen-generating conditions as seen in yeast cells Molecules 17 2012 10355 10369
5. Y. Niu, L. Na, and R. Feng et al the phytochemical, EGCG, extends lifespan by reducing liver and kidney function damage and improving age-associated inflammation and oxidative stress in healthy rats Aging Cell 2013 [Epub ahead of print]
6. B. Richi, R.K. Kale, and A.B. Tiku Radio-modulatory effects of green tea catechin EGCG on pBR322 plasmid DNA and murine splenocytes against gamma-radiation induced damage Mutat Res 747 2012 62 70
7. F. Wu, H. Sun, and T. Kluz et al. Epigallocatechin-3-gallate (EGCG) protects against chromate-induced toxicity in vitro Toxicol Appl Pharmacol 258 2012 166 175
8. A. Hsu, R.S. Bruno, and C.V. Löhr et al. Dietary soy and tea mitigate chronic inflammation and prostate cancer via NFκB pathway in the Noble rat model J Nutr Biochem 22 2011 502 510
9. X. Qi Reactive oxygen species scavenging activities and inhibition on DNA oxidative damage of dimeric compounds from the oxidation of (-)-epigallocatechin-3-O-gallate Fitoterapia 81 2010 205 209
10. H. Yoshioka, H. Kurosaki, and K. Yoshinaga et al. Beta ray-induced scission of DNA in tritiated water and protection by a green tea percolate and (-)-epigallocatechin gallate Biosci Biotechnol Biochem 61 1997 1560 1563 (Pubitemid 127472983)
11. Y. Hu, J.J. Cao, and P. Liu et al. Protective role of tea polyphenols in combination against radiation-induced haematopoietic and biochemical alterations in mice Phytother Res 25 2011 1761 1769
12. H.J. Lee, J.S. Kim, and C. Moon et al. Modification of gamma-radiation response in mice by green tea polyphenols Phytother Res 22 2008 1380 1383
13. Z. Peng, Z.W. Xu, W.S. Wen, and R.S. Wang Tea polyphenols protect against irradiation-induced injury in submandibular glands' cells: a preliminary study Arch Oral Biol 56 2011 738 743
14. G. Zhang, Y. Wang, and Y. Zhang et al. Anti-cancer activities of tea epigallocatechin-3-gallate in breast cancer patients under radiotherapy Curr Mol Med 12 2012 163 176
15. M. Pijls-Johannesma, R. Houben, and L. Boersma et al. High-dose radiotherapy or concurrent chemo-radiation in lung cancer patients only induces a temporary, reversible decline in QoL Radiother Oncol 91 2009 443 448
16. C.M. Kerksick, M.D. Roberts, and V.J. Dalbo et al. Changes in skeletal muscle proteolytic gene expression after prophylactic supplementation of EGCG and NAC and eccentric damage Food Chem Toxicol 2013 pii: S0278-6915(13)00064-1. [Epub ahead of print]
17. J. Nijkamp, M. Rossi, and J. Lebesque et al. Relating acute esophagitis to radiotherapy dose using FDG-PET in concurrent chemo-radiotherapy for locally advanced non-small cell lung cancer Radiother Oncol 106 2013 118 123
18. J. Zhu, Z.C. Zhang, and B.S. Li et al. Analysis of acute radiation-induced esophagitis in non-small-cell lung cancer patients using the Lyman NTCP model Radiother Oncol 97 2010 449 454
19. J.L. Guerra, D. Gomez, and Q. Wei et al. Association between single nucleotide polymorphisms of the transforming growth factor β1 gene and the risk of severe radiation esophagitis in patients with lung cancer Radiother Oncol 105 2012 299 304
20. J. Rose, G. Rodrigues, and B. Yaremko et al. Systematic review of dose-volume parameters in the prediction of esophagitis in thoracic radiotherapy Radiother Oncol 91 2009 282 287
21. M. Feng, D.E. Smith, and D.P. Normolle et al. A phase I clinical and pharmacology study using amifostine as a radioprotector in dose-escalated whole liver radiation therapy Int J Radiat Oncol Biol Phys 83 2012 1441 1447
22. R.P. Hill, A. Zaidi, J. Mahmood, and S. Jelveh Investigations into the role of inflammation in normal tissue response to irradiation Radiother Oncol 101 2011 73 79
23. Y.R. Lawrence, R. Paulus, and C. Langer et al the addition of amifostine to carboplatin and paclitaxel based chemoradiation in locally advanced non-small cell lung cancer: long-term follow-up of Radiation Therapy Oncology Group (RTOG) randomized trial 9801 Lung Cancer 80 2013 298 305
24. B.N. Singh, S. Shankar, and R.K. Srivastava Green tea catechin, epigallocatechin-3gallate (EGCG): mechanisms, perspectives and clinical applications Biochem Pharmacol 82 2011 1807 1821
25. V. de Rosa, P. Erkekoǧlu, and A. Forestier et al. Low doses of selenium specifically stimulate the repair of oxidative DNA damage in LNCaP prostate cancer cells Free Radic Res 46 2012 105 116
26. A. Hallqvist, B. Bergman, and J. Nyman Health related quality of life in locally advanced NSCLC treated with high dose radiotherapy and concurrent chemotherapy or cetuximab-pooled results from two prospective clinical trials Radiother Oncol 104 2012 39 44
27. B. Groselj, M. Kerr, and A.E. Kiltie Radiosensitisation of bladder cancer cells by panobinostat is modulated by Ku80 expression Radiother Oncol 2013 pii: S0167-8140(13)00300-9. [Epub ahead of print]
28. D. Trudel, D.P. Labbé, and M. Araya-Farias et al. A two-stage, single-arm, phase II study of EGCG-enriched green tea drink as a maintenance therapy in women with advanced stage ovarian cancer Gynecol Oncol 2013 pii: S0090-8258(13)01104-9. [Epub ahead of print]
29. M. Poudenx, P.Y. Bondiau, and E. Chamorey et al. Cisplatin-docetaxel induction plus concurrent 3-D conformal radiotherapy and weekly chemotherapy for locally advanced non-small cell lung cancer patients: a phase II trial Oncology 83 2012 321 328
30. N. Rodríguez, M. Algara, and P. Foro et al. Predictors of acute esophagitis in lung cancer patients treated with concurrent three-dimensional conformal radiotherapy and chemotherapy Int J Radiat Oncol Biol Phys 73 2009 810 817
31. W. Uyterlinde, C. Chen, and M. Kwint et al. Prognostic parameters for acute esophagus toxicity in intensity modulated radiotherapy and concurrent chemotherapy for locally advanced non-small cell lung cancer Radiother Oncol 107 2013 392 397